Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (31-40 of 246) with videos related to

Pageof 25
Sort By:
Leukemia|December 2, 2022
A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomasBrunangelo Falini, Giovanni Martino, Stefano Lazzi
Blood|February 10, 2022
How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitorsBrunangelo Falini, Luca De Carolis, Enrico Tiacci
Blood|August 25, 2016
BRAF V600E mutation in hairy cell leukemia: from bench to bedsideBrunangelo Falini, Maria Paola Martelli, Enrico Tiacci
American Journal of Hematology|January 25, 2023
Mutant NPM1: Nuclear export and the mechanism of leukemogenesisBrunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti
Current Opinion in Oncology|September 23, 2009
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectivesBrunangelo Falini, Paolo Sportoletti, Maria Paola Martelli
Blood|November 10, 2020
How I diagnose and treat NPM1-mutated AMLBrunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
The New England Journal of Medicine|September 17, 2015
Dactinomycin in NPM1-Mutated Acute Myeloid LeukemiaBrunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
Leukemia|September 22, 2023
The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML?Brunangelo Falini, Bjorn T Gjertsen, Vibeke Andresen
Nature Reviews. Cancer|May 26, 2006
Evolving concepts in the pathogenesis of hairy-cell leukaemiaEnrico Tiacci, Arcangelo Liso, Miguel Piris, et al.
Leukemia & Lymphoma|June 29, 2012
The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosisTamar Tadmor, Enrico Tiacci, Brunangelo Falini, et al.
Pageof 25

Showing results (31-40 of 246) with videos related to

Sort By:
Pageof 25
Leukemia|December 2, 2022
A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomasBrunangelo Falini, Giovanni Martino, Stefano Lazzi
Blood|February 10, 2022
How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitorsBrunangelo Falini, Luca De Carolis, Enrico Tiacci
Blood|August 25, 2016
BRAF V600E mutation in hairy cell leukemia: from bench to bedsideBrunangelo Falini, Maria Paola Martelli, Enrico Tiacci
American Journal of Hematology|January 25, 2023
Mutant NPM1: Nuclear export and the mechanism of leukemogenesisBrunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti
Current Opinion in Oncology|September 23, 2009
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectivesBrunangelo Falini, Paolo Sportoletti, Maria Paola Martelli
Blood|November 10, 2020
How I diagnose and treat NPM1-mutated AMLBrunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
The New England Journal of Medicine|September 17, 2015
Dactinomycin in NPM1-Mutated Acute Myeloid LeukemiaBrunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
Leukemia|September 22, 2023
The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML?Brunangelo Falini, Bjorn T Gjertsen, Vibeke Andresen
Nature Reviews. Cancer|May 26, 2006
Evolving concepts in the pathogenesis of hairy-cell leukaemiaEnrico Tiacci, Arcangelo Liso, Miguel Piris, et al.
Leukemia & Lymphoma|June 29, 2012
The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosisTamar Tadmor, Enrico Tiacci, Brunangelo Falini, et al.
Pageof 25